All Companies

ZTSCongressional Stock Trades

ZOETIS INC.

Pharmaceutical Preparations

Congressional stock trades in ZOETIS INC. (ZTS) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

25

Politicians Trading

9

Last Traded

Aug 3, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Byron DonaldsRJul 15, 2026Jun 9, 2026Buy$1,001 - $15,000-13.14%
Byron DonaldsRJul 15, 2026Jun 9, 2026Buy$1,001 - $15,000-13.14%
Lisa C. McClainRSep 12, 2025Aug 4, 2025Sell$1,001 - $15,000-52.97%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Buy$1,001 - $15,000-52.77%
Lisa C. McClainRAug 13, 2025Jan 15, 2025Sell$1,001 - $15,000-57.29%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$15,001 - $50,000-55.90%
Robert BresnahanRMay 31, 2025May 15, 2025Buy$1,001 - $15,000-55.47%
Jefferson ShreveRMay 8, 2025Apr 17, 2025Sell$15,001 - $50,000-51.97%
Jefferson ShreveRMay 8, 2025Apr 7, 2025Buy$15,001 - $50,000-52.11%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000-50.56%
Jefferson ShreveRApr 11, 2025Mar 5, 2025Buy$15,001 - $50,000-57.25%
Robert BresnahanRMar 27, 2025Feb 25, 2025Sell$1,001 - $15,000-57.63%

Price History

About ZOETIS INC.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.